Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining carboplatin with irinotecan
in treating patients who have glioblastoma multiforme.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health